Study to Determine Protective Efficacy Against Otitis Media and Assess Safety of an Investigational Pneumococcal Vaccine 2189242A in Healthy Infants.
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Pneumococcal vaccine (Primary) ; Hib vaccine conjugate; Pneumococcal 13-valent CRM197 vaccine conjugate
- Indications Haemophilus infections; Otitis media; Pneumococcal infections; Streptococcal infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 02 Aug 2016 Status changed from active, no longer recruiting to completed.
- 15 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Jul 2016.
- 15 Jul 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jul 2016.